Imprimis Pharmaceuticals Inc., a specialty pharmaceutical company, has expanded the availability of its proprietary ophthalmic and urologic compounded formulations to physicians and patients in Texas. Read More »

Walgreens Boots Alliance Inc. on Monday appointed Kimberly R. Scardino as its new senior vice president, global controller and chief accounting officer, effective immediately. Read More »

Mill City Gold Corp. on Tuesday announced that it has signed a letter of agreement to acquire 100 percent of the issued and outstanding shares of Florida Pharmacy Solutions Inc., a pharmaceutical compounding company located in Zephyrhills, Florida. Read More »

Cambia Health Solutions promoted Scott Powers to president of government programs, with responsibility over the performance of the company's Medicare and Federal Employee Programs areas of business. Read More »

Sentrian said on Thursday that the Food and Drug Administration (FDA) has decided the company's Remote Patient Intelligence (RPI) mobile-health system meets the definition of a "medical device," on which the FDA intends to exercise "enforcement discretion." Read More »

Injured Workers’ Pharmacy LLC today announced that it has completed the acquisition of Chronic Care Inc., doing business as MH Express Pharmacy, a workers’ compensation home delivery pharmacy operating exclusively in California. Read More »

OptimizeRx Corp. today announced that Allscripts, a global leader in healthcare information technology solutions, will expand its partnership to automate voucher and copay savings support within OptimizeRx’s Touchworks electronic health record platform. Read More »

The Food and Drug Administration last week approved a new cholesterol medication called Praluent, the first injection in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. Read More »

RxResults, a Little Rock, Arkansas-based pharmacy risk-management company, said this week that its MemberChoice program is a smart option for employers who want to help their health-plan members save money. Read More »

Pharmacy Times and U.S. News & World Report honored Cetaphil as the No. 1 Pharmacist Recommended brand in the Therapeutic Skin Care Cleansers category for the third year in a row, Cetaphil said on Thursday. Read More »

National Drug Take-Back Day scheduled for 10 a.m. to 2 p.m. Sept. 26 Read More »

CVS Health and IBM said on Thursday that they will use predictive analytics and cognitive computing to transform care-management services for patients with chronic diseases. Read More »

The California Chamber of Commerce said Wednesday it is opposed to a proposed health care bill because it would restrict the ability of health insurers and pharmacy benefit managers (PBM) to control health care costs and would place strict caps on prescription drug copayments, therefore shifting costs, encouraging utilization of expensive medications and reducing flexibility. Read More »

Centric Health Corporation, a Canadian healthcare services company, announced on Wednesday that A. Rik Ganderton will be appointed as an independent member of the board of directors, effective Aug. 5. Read More »

The National Community Pharmacists Association (NCPA) has submitted comments in response to the Medicaid managed care proposed rule from the Centers for Medicare and Medicaid Services, expressing the need for improvements within the proposal. Read More »

Part D costs per capita grew by almost 11 percent in 2014. Read More »

The Utilization Review Accreditation Commission (URAC) has opened a public comment period through Aug. 31 on measurement standards related to its line of pharmacy accreditation products. Read More »

The Government Accountability Office (GAO) released a report Monday that found better communications with pharmacies and other stakeholders can help control prescription drug abuse while guaranteeing that patient access to medications is not compromised. The report studied the interaction between the Drug Enforcement Agency (DEA) and government and industry stakeholders in curbing prescription drug abuse and preserving patient access to medications. Read More »

California Assembly Bill 339 aims to rein in prescription-drug prices to ease the economic impact on those with chronic medical conditions who need expensive drugs, but critics are warning that it also would increase insurance premiums for everyone else and make it harder for insurers to obtain lower-cost drugs. Read More »

Gerresheimer AG, a partner to the pharma and health care industry worldwide, announced today it will extend its pharmaceutical packaging business with the acquisition of Centor US Holding, Inc. Read More »